Unresectable Salivary Gland Carcinoma

specific

Salivary gland carcinoma that is not amenable to surgical resection.

33

Centers

45

Active Trials

Cancer Funding

Top Centers for Unresectable Salivary Gland Carcinoma(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.7
2
High-Volume Research Center
72.7
3
NCI Comprehensive
Active Research Program
65.8
4
NCI Comprehensive
Active Research Program
65.8
565.8
6
NCI Comprehensive
Active Research Program
65.8
7
NCI Comprehensive
Active Research Program
65.8
8
NCI Comprehensive
Active Research Program
65.8
9
NCI Comprehensive
Active Research Program
65.8
10
NCI Comprehensive
Active Research Program
65.8
11
NCI Comprehensive
Active Research Program
44.7
12
NCI Comprehensive
Active Research Program
44.7
13
NCI Comprehensive
Active Research Program
44.7
14
NCI Comprehensive
Active Research Program
44.7
15
NCI Comprehensive
Active Research Program
44.7
16
NCI Comprehensive
Active Research Program
44.7
17
NCI Comprehensive
Active Research Program
44.7
18
NCI Comprehensive
Active Research Program
44.7
19
NCI Comprehensive
Active Research Program
44.7
20
NCI Comprehensive
Active Research Program
44.7
21
NCI Comprehensive
Active Research Program
44.7
22
NCI Comprehensive
Active Research Program
44.7
23
NCI Clinical
Active Research Program
44.7
24
Active Research Program
44.7
25
NCI Comprehensive
Active Research Program
44.7
26
NCI Comprehensive
Active Research Program
44.7
27
NCI Comprehensive
Active Research Program
44.7
28
NCI Clinical
Active Research Program
44.7
29
NCI Comprehensive
Active Research Program
44.7
30
NCI Comprehensive
Active Research Program
44.7
31
Active Research Program
44.7
32
Active Research Program
44.7
33
Active Research Program
44.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →